+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

From
Rituximab - Global Strategic Business Report - Product Thumbnail Image

Rituximab - Global Strategic Business Report

  • Report
  • October 2025
  • 378 Pages
  • Global
From
From
Laryngeal Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Laryngeal Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 273 Pages
  • Global
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 396 Pages
  • Global
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 267 Pages
  • Global
From
Oncolytic Virotherapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virotherapy - Global Strategic Business Report

  • Report
  • October 2025
  • 243 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 180 Pages
  • Global
From
From
Personalized Cancer Medicines - Global Strategic Business Report - Product Thumbnail Image

Personalized Cancer Medicines - Global Strategic Business Report

  • Report
  • October 2025
  • 267 Pages
  • Global
From
Anti-Inflammatory Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Inflammatory Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 488 Pages
  • Global
From
Oncolytic Virus Immunotherapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Immunotherapy - Global Strategic Business Report

  • Report
  • October 2025
  • 383 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Global Strategic Business Report

  • Report
  • October 2025
  • 376 Pages
  • Global
From
From
From
Metastatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Metastatic Cancer Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 377 Pages
  • Global
From
Hedgehog Pathway Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Hedgehog Pathway Inhibitors - Global Strategic Business Report

  • Report
  • October 2025
  • 102 Pages
  • Global
From
Adenoid Cystic Carcinoma - Global Strategic Business Report - Product Thumbnail Image

Adenoid Cystic Carcinoma - Global Strategic Business Report

  • Report
  • October 2025
  • 386 Pages
  • Global
From
From
Oncolytic Virus Therapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virus Therapy - Global Strategic Business Report

  • Report
  • October 2025
  • 483 Pages
  • Global
From
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more